HuR Plays a Role in Double-Strand Break Repair in Pancreatic Cancer Cells and Regulates Functional BRCA1-Associated-Ring-Domain-1(BARD1) Isoforms
Open Access
Abstract
Human Antigen R (HuR/ELAVL1) is known to regulate stability of mRNAs involved in pancreatic ductal adenocarcinoma (PDAC) cell survival. Although several HuR targets are established, it is likely that many remain currently unknown. Here, we identified BARD1 mRNA as a novel target of HuR. Silencing HuR caused a >70% decrease in homologous recombination repair (HRR) efficiency as measured by the double-strand break repair (pDR-GFP reporter) assay. HuR-bound mRNAs extracted from RNP-immunoprecipitation and probed on a microarray, revealed a subset of HRR genes as putative HuR targets, including the BRCA1-Associated-Ring-Domain-1 (BARD1) (p < 0.005). BARD1 genetic alterations are infrequent in PDAC, and its context-dependent upregulation is poorly understood. Genetic silencing (siRNA and CRISPR knock-out) and pharmacological targeting of HuR inhibited both full length (FL) BARD1 and its functional isoforms (α, δ, Φ). Silencing BARD1 sensitized cells to olaparib and oxaliplatin; caused G2-M cell cycle arrest; and increased DNA-damage while decreasing HRR efficiency in cells. Exogenous overexpression of BARD1 in HuR-deficient cells partially rescued the HRR dysfunction, independent of an HuR pro-oncogenic function. Collectively, our findings demonstrate for the first time that BARD1 is a bona fide HuR target, which serves as an important regulatory point of the transient DNA-repair response in PDAC cells.Keywords
Funding Information
- National Cancer Institute (NIH-NCI RO1 CA212600)
- Pancreatic Cancer Action Network (15-90-25-BROD, 21-20-JAIN)
This publication has 67 references indexed in Scilit:
- High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder CancerPLOS ONE, 2013
- Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcomeBritish Journal of Cancer, 2012
- Common Variation atBARD1Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and OncogenicityCancer Research, 2012
- BARD1 Expression Predicts Outcome in Colon CancerClinical Cancer Research, 2011
- Integrative Regulatory Mapping Indicates that the RNA-Binding Protein HuR Couples Pre-mRNA Processing and mRNA StabilityMolecular Cell, 2011
- Cytoplasmic Accumulation of the RNA-binding Protein HuR Stabilizes the Ornithine Decarboxylase Transcript in a Murine Nonmelanoma Skin Cancer ModelJournal of Biological Chemistry, 2010
- Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesisNature Reviews Molecular Cell Biology, 2010
- Identification of Transformation-Related Pathways in a Breast Epithelial Cell Model Using a Ribonomics ApproachCancer Research, 2008
- Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosisInternational Journal of Cancer, 2005
- Loss of Bard1, the Heterodimeric Partner of the Brca1 Tumor Suppressor, Results in Early Embryonic Lethality and Chromosomal InstabilityMolecular and Cellular Biology, 2003